Tempus ECG-Low EF vs Study Watch with Irregular Pulse Monitor (Home)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Tool A is an AI software designed to analyze 12-lead ECGs in clinical settings to detect signs of low left ventricular ejection fraction, aiding in heart failure risk identification. In contrast, Tool B is a wearable device focused on unobtrusive, continuous physiological data collection, including on-demand single-channel ECG and irregular pulse monitoring for atrial fibrillation detection, suitable for remote use or clinical research. While both leverage AI and ECG data for cardiac health, their distinct focus areas (LVEF diagnosis vs. AFib monitoring/data collection) and deployment models make them adjacent rather than direct competitors.

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if your primary need is a rapid, AI-powered screening tool within a clinical diagnostic setting to identify patients aged 40 or older who may be at risk for low left ventricular ejection fraction. This software is ideal for integrating into existing healthcare facility workflows to aid clinicians in prioritizing further evaluation based on standard 12-lead ECGs.

View Tempus ECG-Low EF →

Choose Study Watch with Irregular Pulse Monitor (Home) if…

Choose the Verily Study Watch with Irregular Pulse Monitor (Home) if you require a prescription-only wearable device for unobtrusive, continuous, or on-demand physiological data collection, particularly for remote monitoring of irregular pulse (AFib) in a patient's home environment or for clinical research. This tool excels at long-term data acquisition and cloud-based analytics beyond a single point-in-time ECG.

View Study Watch with Irregular Pulse Monitor (Home) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Tempus ECG-Low EF Study Watch with Irregular Pulse Monitor (Home)
Deployment Integrates with current ECG platforms and electronic health records (EHRs). Unknown
FDA Status Cleared AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tempus ECG-Low EF

Tempus ECG-Low EF integrates directly into existing healthcare facility workflows and Electronic Health Records (EHRs) without requiring a dedicated user interface, making it highly usable for clinicians as it leverages familiar systems. In contrast, the Verily Study Watch, while designed for patient ease of use, requires patients to wear a device and actively participate in data collection, and clinicians access data via a separate web portal.

Clinical Value

Tempus ECG-Low EF

Tempus ECG-Low EF offers high clinical value by addressing the early identification of low Left Ventricular Ejection Fraction (LVEF), a critical indicator for heart failure, using readily available 12-lead ECGs. This can lead to earlier interventions for a prevalent and serious condition. While the Verily Study Watch provides valuable data for AFib detection and broader physiological monitoring, Tool A's specific diagnostic aid for a challenging-to-diagnose condition like low LVEF presents a more direct and impactful clinical utility in a diagnostic setting.

Pricing & Value

Tie

Both tools explicitly state that pricing information is not publicly available and requires contacting the vendor. Without any transparent pricing details for either product, it is impossible to conduct a meaningful comparison of their pricing or assess their relative value.

Enterprise Readiness

Tempus ECG-Low EF

Tempus ECG-Low EF integrates seamlessly into existing healthcare facility workflows and EHR systems via standard protocols, minimizing disruption for enterprise adoption. While Verily Study Watch is designed for clinical research and offers global deployment and support, managing a fleet of wearable devices and patient compliance can introduce more logistical complexities for a healthcare enterprise compared to a software-only solution. The mention of a past HIPAA lawsuit for Verily, even if historical, could also be a minor concern for some organizations.

Innovation

Study Watch with Irregular Pulse Monitor (Home)

The Verily Study Watch demonstrates broader innovation through its comprehensive wearable platform, integrating multiple physiological and environmental sensors for continuous, unobtrusive data collection in real-world settings. This multi-sensor approach and its application in diverse clinical research, including Parkinson's and sleep studies, represent a more expansive and versatile technological advancement compared to Tool A's focused AI application on existing ECG data.

Support & Docs

Study Watch with Irregular Pulse Monitor (Home)

Verily provides a more comprehensive suite of support resources, including online forums, tutorials, product documentation for its Data Workbench and Site CTMS, and a user manual for the Study Watch itself. Additionally, Verily explicitly mentions around-the-clock technical and device assistance, direct participant and site support, and global clinical operations, indicating a robust support infrastructure. While Tempus provides Instructions for Use and validation documents, it lacks the breadth of publicly available support and documentation details seen with Verily.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Tempus ECG-Low EF Study Watch with Irregular Pulse Monitor (Home)
Name Tempus ECG-Low EF Study Watch with Irregular Pulse Monitor (Home)
Company Tempus AI Verily Life Sciences LLC
Description Tempus ECG-Low EF is an FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring, with advanced sensors and cloud-based analytics.
Primary Function Detects signs of low Left Ventricular Ejection Fraction (LVEF u226440%) On-demand single-channel ECG measurement; Irregular pulse monitoring for atrial fibrillation (AFib) detection
Target Patient Population/Use Patients 40+ years at risk of heart failure Clinical research and prescription use
Data Input 12-lead ECG recordings On-demand single-channel ECG measurement, multiple physiological sensors (heart rate, electrodermal activity, inertial movements), environmental sensors

Videos

Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and Study Watch with Irregular Pulse Monitor (Home).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tempus ECG-Low EF is an AI software designed to analyze 12-lead ECGs to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients at risk of heart failure. The Verily Study Watch with Irregular Pulse Monitor (Home) is a wearable device for clinical research and prescription use, focusing on on-demand single-channel ECG measurement and irregular pulse monitoring for atrial fibrillation (AFib) detection.
Tempus ECG-Low EF analyzes standard 12-lead ECG recordings to identify signs of low LVEF. The Verily Study Watch provides on-demand single-channel ECG measurements for irregular pulse monitoring and other physiological data collection.
Tempus ECG-Low EF is intended for use in clinical diagnostic settings at healthcare facilities to aid in identifying patients 40 years or older at risk of heart failure. The Verily Study Watch is a prescription-only wearable device primarily for clinical research and healthcare use, collecting data remotely.
Tempus ECG-Low EF provides a binary output (Low LVEF Detected / Not Detected) to aid clinicians in further evaluation of heart failure risk. The Verily Study Watch offers irregular pulse monitoring for AFib detection and provides various physiological data through cloud-based analytics.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.